Office Use Terms and Conditions

Section 1. Responsibilities of VET: 

1.1. Office Use. VET agrees and acknowledges that all Office Use Prescriptions purchased from a Covetrus pharmacy or other licensed facility may only be administered and dispensed pursuant to the Board of Pharmacy rules, state statutes and regulations where the VET is located.

1.2. Adverse Reactions. VET agrees and acknowledges that all adverse events or reactions involving OU Products shall be reported as follows:

a. VET shall call the fulfilling pharmacy or licensed facility within 24 hours of the reporting to the veterinarian of an adverse event or reaction to report such event.

b. The report shall include the following: Drug name, drug strength, drug lot number, drug beyond-use date, dosage given, date of first exposure, date of last exposure, time between dose and reaction, description of reaction, pet owner name, pet owner contact information, and animal species.

1.3. Schedule II, III, IV, or V Controlled Preparations. VET agrees and acknowledges that Schedule II, III, IV, or V compounded preparations purchased from COVETRUS for office use dispensing will only be administered and dispensed pursuant to Board of Pharmacy rules, and all applicable state and federal statutes and regulations. VET understands and agrees that additional information may be required to be presented to the fulfilling pharmacy or licensed entity for such purchases.

1.4. VET represents and warrants they (a) will only administer the compounded drug to the patient, not dispense or sell to any other person or entity; (b) will include on the patient’s chart, medication order, or medication administration record the lot number and the beyond-use-date of any compounded drug
administered to the patient that was provided by COVETRUS; and (c) will provide notification to the patient for the reporting of any adverse reaction or complaint in order to facilitate any recall of batches of compounded drugs.

Section 2. Responsibilities of COVETRUS:

2.1. Pharmacy Locations: VET acknowledges that Covetrus owns and operates several licensed pharmacies and licensed facilities in the United States and that orders may be filled by any one of these entities.

2.2. Recall Procedures. COVETRUS shall notify VET in a timely manner in the event of a recall of compounded or other pharmaceutical OU Product. Any written notices will include the product name, affected lot number, expiration date, date dispensed, and instructions for disposition of the product and refund procedures.

2.3. For practices located in the State of Georgia: GDNA Agency Notice. COVETRUS SHALL NOTICE THE Georgia Drugs and Narcotics Agency (GDNA) that it provides OU Products to VET and shall retain receipt of such notice and written acknowledgement from GDNA on file.

Version last updated 09.09.2025